Colostrinin, and uses thereof

Details Colostrinin, and uses thereof Colostrinin, and uses thereof

2005-02-08

2005-02-08

Tate, Christopher (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C514S012200, C514S015800, C530S300000, C530S328000, C530S350000

Reexamination Certificate

active

06852700

ABSTRACT:
The use of Colostrinin as a medicament, particularly in the treatment of chronic disorders of the central nervous system and the immune system.

REFERENCES:
patent: 5710132 (1998-01-01), Moller et al.
patent: 9743905 (1997-11-01), None
patent: 2289278 (1995-11-01), None
patent: 9814473 (1998-04-01), None
patent: 208089 (1989-04-01), None
patent: 9705884 (1997-02-01), None
Kruzel, Journal of Molecular Neuroscience, 2001, 17, pp. 379-389.*
Inglot, Archivum Immunologiae et Therapiae Experimentalis, 1996, 44, pp. 215-224.*
Janusz, Archivum Immunologiae et Therapiae Experimentalis, 1993, 41, pp. 275-279.*
Inglot et al.,Archivum Immun. et Ther. Exper.,vol. 44, 1996, pp. 215-224.*
Burrin, “Nutrient-independent and nutrient-dependent factors stimulate protein synthesis in colostrum-fed newborn pigs” 1995, Pediatric Research, vol. 37, pp-593-599.*
Staroscik et al, Molecular Immunology, vol. 30, No. 12, pp. 1277-1282, 1983.*
Haraba et al, Arch. Immun. Ther. Exp. 1986, pp. 437-443.*
Zimecki, Arch. Immun Ther. Exp. 1991, pp. 461-467.*
Janusz et al., Arch. Immun. Ther. Exp., 1993, pp. 175-279.*
Janusz et al., Isolation And Characterization Of A Poline-Rich Polypeptide From Ovine Colostrum, FEBS Letters, vol. 49, No. 2, Dec. 1974, pp. 276-279.
Janusz et al., “Chemical and physical characterization of a proline-rich polypeptide from sheep colostrum,” The Biochemical Journal, vol. 1999, pp. 9-15, 1981.
Starościk et al., “Immunologically Active Nonpeptide Fragment Of A Proline-Rich Polypeptide From Ovine Colostrum: Amino Acid Sequence And Immunoregulatory Properties,” Molecular Immunology, vol. 30., No. 12, pp. 1277-1282, 1983.
Japanese Patent Abstract, Application No. 01085119, Publication No. 02265458, Publication Date Oct. 30, 1990.
Hraba et al., “Effect of Proline-Rich Polypeptide on Experimental Autoimmune Response to Erythrocytes,” Archivum Immunolgiae et Therapiae Experimentalis, 1986, pp. 437-443.
Zimecki et al., “Effect of a Proline-Rich Polypeptide (PRP) on the Development of Hemolytic Anemia and Survival of New Zealand Black (NZB) Mice,” Archivum Immunologiae et Therapiae Experimentalis, 1991, pp. 461-467.
Unlisted Drugs, Mar. 1989, vol. 41, No. 3, p. 52.
Janusz et al., “Proline-Rich Polypeptide (PRP)—an Immunomodulatory Peptide from Ovine Colostrum,” Archivum Immunologiae et Therapiae Experimentalis, 1993, pp. 175-279.
Inglot et al., “Colostrinine: a Proline-Rich Polypeptide from Oviine Colostrum Is a Modest Cytokine Inducer in Human Leukocytes,” Archivum Immunologiae et Therapiae Experimentalis, 1996, pp. 215-223.
Abstract entitled “Colostrinin For Treatment Of Alzheimer's Disease,” European Cytokine Network vol. 7, No. 3—Estimated Publication Oct. 4, 1996.

Affiliated with

Also associated with

Rating

Colostrinin, and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Colostrinin, and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Colostrinin, and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3508343